FDA considers 'substantially inferior' heart drug


FDA considers ‘substantially inferior’ heart drug

Image copyright Merck Image caption The first clinical trials of a generic form of the heart attack-preventing drug – known as semagacestat – began in 1997 A panel of the US Food and Drug…

Sakkari advances to WTA Finals


Sakkari advances to WTA Finals

Written by Staff Writer Staff Writer After the excitement of winning a maiden WTA Tour title in Montreal on Friday, Maria Sakkari of Greece is making the most of her opportunity to get one…